Medication info

Albitin Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
This medication is a round white film-coated tablet.
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201406179 · Approved 2014.12.31

This product's status changed to Expired on 2024.12.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, administer 2 tablets orally twice daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks; however, the healing period may sometimes be longer, depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, in patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • reflux esophagitis
  • Mendelson's syndrome
  • post-surgery ulcer
  • gastric ulcer due to NSAIDs
  • duodenal ulcer due to NSAIDs
View approved original text

This medication is used to treat various digestive system issues such as gastric and duodenal ulcers, gastritis, and reflux esophagitis. It also suppresses excessive gastric acid secretion caused by Zollinger-Ellison syndrome and helps prevent ulcers that may occur post-surgery. Administered before anesthesia, it prevents Mendelson's syndrome and is effective in treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to improve various gastrointestinal diseases.

How to take

Adult dose

○ Adults Usually, administer 2 tablets orally twice daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks; however, the healing period may sometimes be longer, depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, in patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or with impaired kidney function. Additionally, it should not be administered to patients who have had allergic reactions to this medication or its ingredients, patients with a history of acute porphyria, patients who have undergone gastric surgery, pregnant women or those who might become pregnant, premature infants and newborns, and patients on a dietary regimen that restricts potassium intake. Patients with liver dysfunction, a history of hypersensitivity reactions, the elderly, patients with a history of kidney diseases, and those taking non-steroidal anti-inflammatory drugs should exercise caution when administering this medication. Particularly, since it may mask symptoms of gastric cancer, patients with gastric ulcers and middle-aged or older patients who have newly developed or changed dyspeptic symptoms should be assessed for malignancy before use. Patients with gastric or duodenal ulcers who are infected with Helicobacter pylori should receive eradication therapy, and severely ill patients in intensive care or those with hypophosphatemia and patients who have difficulty swallowing should also be cautious when administering this medication. This medication can rarely cause severe allergic reactions or shock; therefore, if any abnormal symptoms appear during use, stop the medication immediately and seek appropriate treatment. Allergic symptoms such as skin rash, hives, angioedema, fever, bronchospasm, hypotension, chest pain, etc., may occur, so caution is advised. Regular blood tests are required as leukopenia, thrombocytopenia, or liver function abnormalities may appear in blood tests. Various side effects have been reported, including cardiac irregularities, gastrointestinal symptoms (nausea, vomiting, diarrhea, etc.), neurological symptoms (dizziness, drowsiness, confusion, seizures, etc.), muscle pain, skin rash, etc. If any abnormal symptoms occur, inform a healthcare provider immediately. If the medication does not provide an effect without long-term use, it is advisable to switch to another drug. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems may have an increased risk of pneumonia, requiring caution. If dizziness or drowsiness occurs while taking this medication, avoid driving or operating hazardous machinery. This medication may interact with other drugs, so particularly when taken alongside anticoagulants, frequent blood tests are necessary, and dosages should be spaced apart from certain antibiotics, anticonvulsants, antacids, etc. Pregnant or breastfeeding women should refrain from using this medication, and safety in pediatric patients has not been established, so it is advisable not to administer it in children. In the case of overdose, treatment such as vomiting or gastric lavage may be necessary, and in severe cases, it can be removed through blood dialysis. This medication decreases gastric acid secretion, which may promote bacterial proliferation in the stomach; therefore, regular screenings, including ocular examinations, are necessary during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 59 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • hypoplasia of bone marrow
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • cholestatic hepatitis
  • non-cholestatic hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • feeling unwell
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • muscular spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that does not allow air to enter, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for a long time.

Appearance and packaging

Appearance

This medication is a round white film-coated tablet.

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.